Back

Depression and anxiety at time of implantable cardioverter defibrillator implantation and the biological link with cardiovascular disease

24 April 2021 (07:30 - 08:30)
Organised by:
Congress Presentation Part of: New insights in ventricular arrhythmias I Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2021

About the speaker

Photo
Miss Anne-Lotte van der Lingen

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
A novel variant in the SLC4A3 gene with high penetrance in a family with short QT Syndrome
Doctor B. Kovacs (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Cardiac arrest in Acute Coronary Syndrome: predictors and prognosis
Doctor M. Santos (Figueira da Foz, PT)
Abstract Slides Video
Presentation thumbnail
A Left sided site of origin is associated with adverse cardiovascular outcomes in patients with LV dysfunction undergoing PVC ablation
Mr D. Penela (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease
Doctor A. Zegard (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
In-vivo endocardial and epicardial quantitative comparison of multi-wave based non-invasive inverse electrocardiography.
Miss M. Boonstra (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
New insights in ventricular arrhythmias I

The Event

Event poster

EHRA 2021

24 April 2021 07:30 CET
You may be interested in
thumbnail
Congress Presentation
New onset depression and anxiety in patients with an implantable cardioverter defibrillator during 24 months of follow-up
24 April 2021
thumbnail
Webinar
Common mechanisms of mood disorders and cardiovascular disease
23 September 2024
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
30 March 2025
thumbnail
Congress Presentation
Severity of depressive disorders in chronic heart failure patients with ischemic heart disease depending on concomitant metabolic disturbances
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources